- Report
- July 2026
- 120 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- April 2026
- 111 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- August 2026
- 182 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- August 2026
- 171 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- January 2026
- 147 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- February 2026
- 200 Pages
Global
From €4594EUR$4,995USD£3,914GBP
- Report
- August 2026
- 160 Pages
Global
From €3054EUR$3,320USD£2,602GBP
€3817EUR$4,150USD£3,252GBP
- Report
- August 2026
- 160 Pages
Global
From €3054EUR$3,320USD£2,602GBP
€3817EUR$4,150USD£3,252GBP
- Report
- January 2026
- 160 Pages
Global
From €2907EUR$3,160USD£2,476GBP
€3633EUR$3,950USD£3,095GBP
- Report
- October 2025
- 160 Pages
Global
From €2907EUR$3,160USD£2,476GBP
€3633EUR$3,950USD£3,095GBP
- Report
- October 2025
- 150 Pages
Global
From €4461EUR$4,850USD£3,801GBP
- Report
- January 2026
- 106 Pages
Global
From €3173EUR$3,450USD£2,704GBP
- Report
- December 2025
Global
From €6898EUR$7,500USD£5,877GBP
- Report
- October 2025
Global
From €6898EUR$7,500USD£5,877GBP
- Report
- December 2022
- 325 Pages
Global
From €4798EUR$5,400USD£3,950GBP
- Report
- October 2023
- 159 Pages
Global
From €4139EUR$4,500USD£3,526GBP
- Report
- April 2024
- 136 Pages
Global
From €2070EUR$2,250USD£1,763GBP
- Report
- July 2022
- 159 Pages
Global
From €2161EUR$2,350USD£1,842GBP
- Report
- August 2022
- 203 Pages
Global
From €4553EUR$4,950USD£3,879GBP
- Report
- May 2023
- 395 Pages
Global
From €3840EUR$4,175USD£3,272GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more